About
Rendiatech is a medical device company dedicated to real-time renal diagnostics. The company’s first commercially available product, Clarity RMS, is a critical care monitoring system that has been clinically proven to facilitate early detection of changes in renal function and acute kidney injury (AKI) risk, in addition to treatment monitoring.
Clarity RMS provides continuous, automatic monitoring of urine flow, enabling better patient care and ICU economics. It also provides additional real-time parameters and expanded diagnostic capabilities to further improve critical care management in the ICU and perioperative setting.
The Clarity RMS system has FDA clearance as well as CE certification and is installed in tens of general and cardiovascular operating rooms, ICUs, and transplant and COVID-19 units in leading medical centers in the U.S., Europe, and Israel. Future sensor-based products will aim to provide additional diagnostic data about renal and other vital organ function beyond the critical care setting.
Funding history · 4 rounds · $29.8M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Rendiatech acquired and by which company?
- Rendiatech was acquired by Nuwellis in August 2025. Nuwellis signed a Letter of Intent to explore the acquisition on August 18, 2025.
- What is Rendiatech's primary product?
- Rendiatech's first commercially available product is Clarity RMS, a critical care monitoring system for real-time renal diagnostics.
- What certifications does Rendiatech's Clarity RMS system hold?
- The Clarity RMS system has FDA clearance and CE certification. The CE Mark was obtained in August 2019.
- How much funding has Rendiatech raised in total?
- Rendiatech has raised a total of $29,828,000 across multiple funding rounds and grants. For a full financing history, refer to startupim.
- When did Rendiatech complete its Series A funding round and who was a lead investor?
- Rendiatech completed its Series A funding round in November 2021, raising $14 million. BlueRed Partners was a lead investor in this round.
- When did Rendiatech receive a grant from the IIA?
- Rendiatech received an $828,000 grant from the IIA in May 2019.
- Which company did Rendiatech partner with for distribution in mainland China?
- In August 2021, Rendiatech announced a distribution agreement in mainland China with Gloryway.
- When did Rendiatech begin delivering its Clarity RMS orders in Europe?
- Rendiatech started the delivery of its first orders of Clarity RMS in Europe in February 2020.
- Where is Rendiatech's headquarters located?
- Rendiatech's headquarters is located at HaMarpe Street 3, Jerusalem, Israel.